BLOOMFIELD HILLS, MICHIGAN--(Marketwired - March 28, 2016) - Intrinsic4D Inc. ("Intrinsic4D") (TSX VENTURE:IFD) announced today that it has signed an engagement letter with New York based Joseph Gunnar & Co., LLC ("Joseph Gunnar"), a leading small-cap investment banking firm, to act as the sole book-runner for an underwriting of a proposed registered U.S. public offering of common stock of Intrinsic4D.

Pursuant to the engagement letter it is anticipated that Intrinsic4D would apply to list its common stock on The NASDAQ Stock Market or such other stock exchange agreed by the parties.

"The United States is an important market for Intrinsic4D both commercially and financially," said Jorey Chernett, CEO of Intrinsic4D. "Gunnar's Global Equity Capital Markets group is the leader in underwriting transactions for companies our size and we look forward to building an ongoing partnership with their experienced team."

The 12-month engagement letter provides the conditions under which Joseph Gunnar will act as the sole underwriter for the firm commitment underwriting of a registered U.S. public offering of approximately $12 million of common stock (the "Offering") by Intrinsic4D. The exact size and terms of the Offering will depend upon certain conditions including the capitalization of Intrinsic4D, and market and general economic conditions at the time of the Offering. The engagement agreement is non-binding and subject to certain conditions including, among other items, satisfactory completion of due diligence by Joseph Gunnar, Intrinsic4D meeting the criteria necessary for listing on a U.S. stock exchange and the negotiation and execution of a definitive underwriting agreement.

About Joseph Gunnar

Joseph Gunnar, founded in 1997, is a full service broker-dealer dedicated to assisting clients in achieving their financial goals by providing a full array of investment products and vehicles to private and corporate clients. Joseph Gunnar is headquartered in New York next to the NYSE. They are a member of FINRA and SIPC.

Company website - www.JosephGunnar.com.

About Intrinsic4D Inc.

Intrinsic4D, through its Authentic brand, is the developer of the patented and FDA-cleared transformative software-as-a-service medical platform servicing the medical-legal industry and through its patented and disruptive Stenosis Severity Mapping (SSM) Cardio solution aims to reduce the $13 billion of unnecessary cardiac catheterizations performed annually, attributed to false positive reads of diagnostic tests for evaluating coronary artery disease.

Company website - www.intrinsic4d.com

Disclaimer for Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws. Forward-looking information may relate to the Corporation's future outlook and anticipated events or results. Particularly, statements regarding future results, performance, achievements and prospects or opportunities for the Corporation are forward looking statements. Some of the specific forward looking statements in this press release include, but are not limited to, Joseph Gunnar's satisfactory due diligence on Intrinsic4D and decision to proceed with the proposed Offering, and the completion of the transactions (the Offering and U.S. exchange listing) contemplated by the engagement letter. Although the forward-looking statements contained in this press release are based upon assumptions that management of the Corporation believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Corporation's control, which may cause actual results to differ materially from those expressed or implied by such forward-looking statements. The forward-looking statements made in this press release relate only to events or information as of the date hereof. Except as required by applicable law, the Corporation undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from the U.S. registration requirements. This news release does not constitute an offer for sale of securities for sale, nor a solicitation for offers to buy any securities. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements.